EC to act on German drug price discounts

The European Commission has now threatened to take the German government to the European Court over the drug price discount regime operated by the country's drugmakers and health funds. Under the recent German health service reform legislation the funds have to conclude framework agreements with the drug companies over discounts. The Commission says that these do not meet European Union rules on transparency and that firms that do not conclude discount agreements are effectively excluded from the national drug market.